Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development (original) (raw)

• Rainsford, K. D. Aspirin and Related Drugs (CRC Press, 2004).
  Google Scholar
• Garavito, R. M. Working Knowledge: aspirin. Sci. Am. 280, 108 (1999).
  Google Scholar
• Gerhardt, C. Untersuchungen über die wasserfreien organischen Säuren. Justus Liebigs Annalen Chemie 87, 57–84 (in German) (1853).
  Google Scholar
• White, N. J. Qinghaosu (artemisinin): the price of success. Science 320, 330–334 (2008). A review of the history and properties of artemisinin.
  CAS PubMed Google Scholar
• Li, Y. & Wu, Y. L. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives? Med. Trop. 58, 9–12 (1998).
  CAS Google Scholar
• World Health Organisation. Guidelines for the treatment of malaria. 2nd edn (WHO, 2010).
• World Health Organisation. WHO informal consultation with manufacturers of artemisinin-based pharmaceutical products in use for the treatment of malaria (WHO, 2007).
• Hale, V., Keasling, J. D., Renninger, N. & Diagana, T. T. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Am. J. Trop. Med. Hyg. 77, 198–202 (2007).
  PubMed Google Scholar
• World Health Organisation. World Malaria Report 2012 (WHO, 2012).
• Hsu, E. Reflections on the 'discovery' of the antimalarial qinghao. Br. J. Clin. Pharmacol. 61, 666–670 (2006).
  PubMed PubMed Central Google Scholar
• Qinghaosu Antimalarial Coordinating Research Group. Antimalaria Studies on Qinghaosu. Chin. Med. J. 12, 811–816 (1979).
• Klayman, D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049–1055 (1985).
  CAS PubMed Google Scholar
• Dalrymple, D. Artemisia Annua, artemisinin, ACTs & malaria control in Africa. Tradition, science and public policy [online], (2012).
  Google Scholar
• Cui, L. & Su, X. Z. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev. Anti-Infective Ther. 7, 999–1013 (2009).
  CAS Google Scholar
• Barnes, K. I., Chanda, P. & Ab Barnabas, G. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J. 8, S8 (2009).
  PubMed PubMed Central Google Scholar
• Cheeseman, I. H. et al. A major genome region underlying artemisinin resistance in Malaria. Science 336, 79–82 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dondorp, A. M. et al. Artemisinin resistance: current status and scenarios for containment. Nature Rev. Microbiol. 8, 272–280 (2010).
  CAS Google Scholar
• Fairhurst, R. M. et al. Artemisinin-resistant Malaria: research challenges, opportunities, and public health implications. Am. J. Trop. Med. Hyg. 87, 231–241 (2012).
  PubMed PubMed Central Google Scholar
• Takala-Harrison, S. et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc. Natl Acad. Sci. 110, 240–245 (2013).
  CAS PubMed Google Scholar
• Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nature Genet. 45, 648–655 (2013).
  CAS PubMed Google Scholar
• Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50–55 (2014). This paper reports the identification of a molecular marker for artemisinin-resistant malaria, which will be important for the tracking and elimination of artemisinin-resistant parasites.
  PubMed Google Scholar
• Shretta, R. & Yadav, P. Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up. Malar J. 11, 399 (2012).
  PubMed PubMed Central Google Scholar
• Dahlberg Global Development Advisors. Independent Mid-Term review of the assured Artemisinin Supply System (A2S2) Project. Geneva: UNITAID [online], (2012).
• Assured Artemisinin Supply System. Artemisinin imports into India [online], (updated 13 January 2014).
• WHO Health Financing. Per capita total expenditure on health at average exchange rate (US $) [online], (2011).
• The World Bank. Health expenditure per capita (current US$). [online] (2013).
• Bertea, C. M. et al. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med. 71, 40–47 (2005).
  CAS PubMed Google Scholar
• Brown, G. D. The biosynthesis of artemisinin (Qinghaosu) and the phytochemistry of Artemisia annua L. (Qinghao). Molecules 15, 7603–7698 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bouwmeester, H. J. et al. Amorpha-4,11-diene synthase catalyses the first probable step in artemisinin biosynthesis. Phytochemistry 52, 843–854 (1999).
  CAS PubMed Google Scholar
• Covello, P. S., Teoh, K. H., Polichuk, D. R., Reed, D. W. & Nowak, G. Functional genomics and the biosynthesis of artemisinin. Phytochemistry 68, 1864–1871 (2007).
  CAS PubMed Google Scholar
• Paddon, C. et al. In Isoprenoid Synthesis in Plants and Microorganisms (eds Bach, T. J. & Rohmer, M.) 91–106 (Springer, 2013).
  Google Scholar
• Zhang, Y. et al. The molecular cloning of artemisinic aldehyde Δ11(13) reductase and its role in glandular trichome-dependent biosynthesis of artemisinin in Artemisia annua. J. Biol. Chem. 283, 21501–21508 (2008).
  CAS PubMed Google Scholar
• Zhao, L., Chang, W. C., Xiao, Y., Liu, H. W. & Liu, P. Methylerythritol phosphate pathway of isoprenoid biosynthesis. Annu. Rev. Biochem. 82, 497–530 (2013).
  CAS PubMed PubMed Central Google Scholar
• Reiling, K. K. et al. Mono and diterpene production in Escherichia coli. Biotechnol. Bioeng. 87, 200–212 (2004).
  CAS PubMed Google Scholar
• Martin, V. J., Pitera, D. J., Withers, S. T., Newman, J. D. & Keasling, J. D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotech. 21, 796–802 (2003). This paper provides a description of the initial amorphadiene production pathway in E. coli.
  CAS Google Scholar
• Martin, V. J., Yoshikuni, Y. & Keasling, J. D. The in vivo synthesis of plant sesquiterpenes by Escherichia coli. Biotechnol. Bioeng. 75, 497–503 (2001).
  CAS PubMed Google Scholar
• Newman, J. D. et al. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol. Bioeng. 95, 684–691 (2006).
  CAS PubMed Google Scholar
• Pitera, D. J., Paddon, C. J., Newman, J. D. & Keasling, J. D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 9, 193–207 (2007).
  CAS PubMed Google Scholar
• Pfleger, B. F., Pitera, D. J., Smolke, C. D. & Keasling, J. D. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nature Biotech. 24, 1027–1032 (2006).
  CAS Google Scholar
• Pfleger, B. F., Pitera, D. J., Newman, J. D., Martin, V. J. & Keasling, J. D. Microbial sensors for small molecules: development of a mevalonate biosensor. Metab. Eng. 9, 30–38 (2007).
  CAS PubMed Google Scholar
• Kizer, L., Pitera, D. J., Pfleger, B. F. & Keasling, J. D. Application of functional genomics to pathway optimization for increased isoprenoid production. Appl. Environ. Microbiol. 74, 3229–3241 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tabata, K. & Hashimoto, S. Production of mevalonate by a metabolically-engineered Escherichia coli. Biotechnol. Lett. 26, 1487–1491 (2004).
  CAS PubMed Google Scholar
• Hedl, M., Tabernero, L., Stauffacher, C. V. & Rodwell, V. W. Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases. J. Bacteriol. 186, 1927–1932 (2004).
  CAS PubMed PubMed Central Google Scholar
• Tsuruta, H. et al. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS ONE 4, e4489 (2009). This study reports strain engineering and fermentation development, which culminated in the production of 25 g per L amorphadiene in E. coli.
  PubMed PubMed Central Google Scholar
• Roth, R. J. & Acton, N. A simple conversion of artemisinic acid into artemisinin. J. Nature Prod. 52, 1183–1185 (1989).
  CAS Google Scholar
• Roth, R. J. & Roth, N. A. Simple conversion of artemisinic acid into artemisinin. US Patent 4992561 (1991).
  Google Scholar
• Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940–943 (2006). This paper describes the isolation of CYP71AV1 — the cytochrome P450 enzyme that oxidizes amorphadiene — and provides the first demonstration of artemisinic acid production in S. cerevisiae.
  CAS PubMed Google Scholar
• Chang, M. C., Eachus, R. A., Trieu, W., Ro, D. K. & Keasling, J. D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nature Chem. Biol. 3, 274–277 (2007).
  CAS Google Scholar
• Lenihan, J. R., Tsuruta, H., Diola, D., Renninger, N. S. & Regentin, R. Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies. Biotechnol. Prog. 24, 1026–1032 (2008).
  CAS PubMed Google Scholar
• Mortimer, R. K. & Johnston, J. R. Genealogy of principal strains of the yeast genetic stock center. Genetics 113, 35–43 (1986).
  CAS PubMed PubMed Central Google Scholar
• Goffeau, A. et al. Life with 6000 genes. Science 274, 563–567 (1996).
  Google Scholar
• Ben-Ari, G. et al. Four linked genes participate in controlling sporulation efficiency in budding yeast. PLoS Genet. 2, e195 (2006).
  PubMed PubMed Central Google Scholar
• van Dijken, J. P. et al. An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains. Enzyme Microb. Technol. 26, 706–714 (2000).
  CAS PubMed Google Scholar
• Westfall, P. J. et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl Acad. Sci. USA 109, E111–E118 (2012). This paper describes strain engineering and fermentation development, which enabled the production of 40 g per L amorphadiene in S. cerevisiae , followed by the chemical conversion of amorphadiene to dihydroartemisinic acid.
  CAS PubMed Google Scholar
• Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528–532 (2013). This paper describes strain engineering and fermentation development — which enabled the production of 25 g per L artemisinic acid in S. cerevisiae — and an efficient, non-photochemical conversion to artemisinin.
  CAS PubMed Google Scholar
• Ro, D. K. et al. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol. 8, 83 (2008).
  PubMed PubMed Central Google Scholar
• Zangar, R. C., Davydov, D. R. & Verma, S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 199, 316–331 (2004).
  CAS PubMed Google Scholar
• Peterson, J. A., Ebel, R. E., O'Keeffe, D. H., Matsubara, T. & Estabrook, R. W. Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J. Biol. Chem. 251, 4010–4016 (1976).
  CAS PubMed Google Scholar
• Schenkman, J. B. & Jansson, I. The many roles of cytochrome _b_5 . Pharmacol. Ther. 97, 139–152 (2003).
  CAS PubMed Google Scholar
• Zhang, H., Im, S. C. & Waskell, L. Cytochrome _b_5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4. J. Biol. Chem. 282, 29766–29776 (2007).
  CAS PubMed Google Scholar
• Teoh, K. H., Polichuk, D. R., Reed, D. W. & Covello, P. S. Molecular cloning of an aldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia annua. Botany 87, 635–642 (2009). This study reports the identification of the A. annua aldehyde dehydrogenase, which is required for high-level production of artemisinic acid in S. cerevisiae.
  CAS Google Scholar
• Sanofi. Prix Potier 2012 (in French) [online], (2012).
• WHO Prequalificaion of Medicines Programme. Acceptance of non-plant-derived-artemisinin offers potential to increase access to malaria treatment [online], (2013).
• Ajikumar, P. K. et al. Isoprenoid pathway optimization for taxol precursor overproduction in E. coli. Science 330, 70–74 (2010).
  CAS PubMed PubMed Central Google Scholar
• Engels, B., Dahm, P. & Jennewein, S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab. Eng. 10, 201–206 (2008).
  CAS PubMed Google Scholar
• Hawkins, K. M. & Smolke, C. D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nature Chem. Biol. 4, 564–573 (2008).
  CAS Google Scholar
• Minami, H. et al. Microbial production of plant benzylisoquinoline alkaloids. Proc. Natl Acad. Sci. USA 105, 7393–7398 (2008).
  CAS PubMed Google Scholar
• Glenn, W., Runguphan, W. & O'Connor, S. Recent progress in the metabolic engineering of alkaloids in plant systems. Curr. Opin. Biotechnol. 24, 354–365 (2013).
  CAS PubMed Google Scholar
• Nakagawa, A. et al. A bacterial platform for fermentative production of plant alkaloids. Nature Commun. 2, 326 (2011).
  Google Scholar
• DiCarlo, J. E. et al. Genome engineering in Saccharomyces cerevisiae using CRISPR–Cas systems. Nucleic Acids Res. 41, 4336–4343 (2013). This paper reports the use of the CRISPR–Cas system in yeast, which has the potential to markedly advance genome engineering in this organism.
  CAS PubMed PubMed Central Google Scholar
• Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nature Biotech. 31, 233–239 (2013).
  CAS Google Scholar
• Wang, H. H. et al. Programming cells by multiplex genome engineering and accelerated evolution. Nature 460, 894–898 (2009).
  CAS PubMed PubMed Central Google Scholar
• Dicarlo, J. E. et al. Yeast oligo-mediated genome engineering (YOGE). ACS Synth. Biol. 2, 741–749 (2013).
  CAS PubMed PubMed Central Google Scholar
• Lo, H. C. et al. Two separate gene clusters encode the biosynthetic pathway for the meroterpenoids austinol and dehydroaustinol in Aspergillus nidulans. J. Am. Chem. Soc. 134, 4709–4720 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ahuja, M. et al. Illuminating the diversity of aromatic polyketide synthases in Aspergillus nidulans. J. Am. Chem. Soc. 134, 8212–8221 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ma, H., Kunes, S., Schatz, P. J. & Botstein, D. Plasmid construction by homologous recombination in yeast. Gene 58, 201–216 (1987).
  CAS PubMed Google Scholar
• Oldenburg, K. R., Vo, K. T., Michaelis, S. & Paddon, C. Recombination-mediated PCR-directed plasmid construction in vivo in yeast. Nucleic Acids Res. 25, 451–452 (1997).
  CAS PubMed PubMed Central Google Scholar
• Shao, Z. & Zhao, H. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res. 37, e16 (2009).
  PubMed Google Scholar
• Luo, Y. et al. Activation and characterization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster. Nature Commun. 4, 2894 (2013).
  Google Scholar
• Kuijpers, N. et al. A versatile, efficient strategy for assembly of multi-fragment expression vectors in Saccharomyces cerevisiae using 60-bp synthetic recombination sequences. Microb. Cell Factories 12, 47 (2013).
  CAS Google Scholar
• Pachuk, C. J. et al. Chain reaction cloning: a one-step method for directional ligation of multiple DNA fragments. Gene 243, 19–25 (2000).
  CAS PubMed Google Scholar
• Quan, J. & Tian, J. Circular polymerase extension cloning of complex gene libraries and pathways. PLoS ONE 4, e6441 (2009).
  PubMed PubMed Central Google Scholar
• Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods 6, 343–345 (2009).
  CAS PubMed Google Scholar
• de Kok, S. et al. Rapid and reliable DNA assembly via ligase cycling reaction. ACS Synthet. Biol. 3, 97–106 (2014).
  CAS Google Scholar
• Leguia, M., Brophy, J., Densmore, D. & Anderson, J. C. Automated assembly of standard biological parts. Methods Enzymol. 498, 363–397 (2011).
  CAS PubMed Google Scholar
• Nielsen, J. & Keasling, J. D. Synergies between synthetic biology and metabolic engineering. Nature Biotech. 29, 693–695 (2011).
  CAS Google Scholar
• Bailey, J. E. Toward a science of metabolic engineering. Science 252, 1668–1675 (1991). This paper provides an early description and vision of metabolic engineering.
  CAS PubMed Google Scholar
• Woolston, B. M., Edgar, S. & Stephanopoulos, G. Metabolic engineering: past and future. Annu. Rev. Chem. Biomol. Eng. 4, 259–288 (2013).
  CAS PubMed Google Scholar
• Nakamura, C. E. & Whited, G. M. Metabolic engineering for the microbial production of 1,3-propanediol. Curr. Opin. Biotechnol. 14, 454–459 (2003).
  CAS PubMed Google Scholar
• Chen, J., Densmore, D., Ham, T. S., Keasling, J. D. & Hillson, N. J. DeviceEditor visual biological CAD canvas. J. Biol. Eng. 6, 1 (2012).
  PubMed PubMed Central Google Scholar
• Hillson, N. J., Rosengarten, R. D. & Keasling, J. D. j5 DNA assembly design automation software. ACS Synth. Biol. 1, 14–21 (2012).
  CAS PubMed Google Scholar
• Ham, T. S. et al. Design, implementation and practice of JBEI-ICE: an open source biological part registry platform and tools. Nucleic Acids Res. 40, e141 (2012).
  PubMed PubMed Central Google Scholar
• Linshiz, G. et al. PaR–PaR laboratory automation platform. ACS Synth. Biol. 2, 216–222 (2013).
  CAS PubMed Google Scholar
• Mutalik, V. K. et al. Quantitative estimation of activity and quality for collections of functional genetic elements. Nature Methods 10, 347–353 (2013).
  CAS PubMed Google Scholar
• Endy, D. Foundations for engineering biology. Nature 438, 449–453 (2005).
  CAS PubMed Google Scholar
• Gardner, T. S. Synthetic biology: from hype to impact. Trends Biotechnol. 31, 123–125 (2013).
  CAS PubMed Google Scholar
• Andrianantoandro, E., Basu, S., Karig, D. K. & Weiss, R. Synthetic biology: new engineering rules for an emerging discipline. Mol. Syst. Biol. 2, 2006.0028 (2006).
  PubMed PubMed Central Google Scholar
• Stephanopoulos, G. Synthetic biology and metabolic engineering. ACS Synth. Biol. 1, 514–525 (2012).
  CAS PubMed Google Scholar
• Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339–342 (2000).
  CAS PubMed Google Scholar
• Elowitz, M. B. & Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature 403, 335–338 (2000). References 99 and 100 are two of the earliest publications on synthetic biology and demonstrate the potential to apply engineering principles to biology.
  CAS PubMed Google Scholar
• Stemmer, W. P. C., Crameri, A., Ha, K. D., Brennan, T. M. & Heyneker, H. L. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164, 49–53 (1995).
  CAS PubMed Google Scholar
• Mutalik, V. K. et al. Precise and reliable gene expression via standard transcription and translation initiation elements. Nature Methods 10, 354–360 (2013).
  CAS PubMed Google Scholar
• Bonnet, J., Subsoontorn, P. & Endy, D. Rewritable digital data storage in live cells via engineered control of recombination directionality. Proc. Natl Acad. Sci. 109, 8884–8889 (2012).
  CAS PubMed Google Scholar
• Bonnet, J., Yin, P., Ortiz, M. E., Subsoontorn, P. & Endy, D. Amplifying genetic logic gates. Science 340, 599–603 (2013).
  CAS PubMed Google Scholar
• Ajikumar, P. K. et al. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol. Pharm. 5, 167–190 (2008).
  CAS PubMed Google Scholar
• Paltauf, F., Kohlwein, S. D. & Henry, S. A. in The Molecular and Cellular Biology of the Yeast Saccharomyces (eds Jones, E. W., Pringle, J. R. & Broach, J. R.) 425–500 (Cold Spring Harbor Laboratory Press, 1992).
  Google Scholar
• Shiba, Y., Paradise, E. M., Kirby, J., Ro, D. K. & Keasling, J. D. Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. Metab. Eng. 9, 160–168 (2006).
  PubMed Google Scholar
• Eisenreich, W., Bacher, A., Arigoni, D. & Rohdich, F. Biosynthesis of isoprenoids via the non-mevalonate pathway. Cell. Mol. Life Sci. 61, 1401–1426 (2004).
  CAS PubMed Google Scholar
• Putra, S. R., Disch, A., Bravo, J. M. & Rohmer, M. Distribution of mevalonate and glyceraldehyde 3-phosphate/pyruvate routes for isoprenoid biosynthesis in some Gram-negative bacteria and mycobacteria. FEMS Microbiol. Lett. 164, 169–175 (1998).
  CAS PubMed Google Scholar
• Lichtenthaler, H. K. The 1-deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 50, 47–65 (1999).
  CAS PubMed Google Scholar
• Carlsen, S. et al. Heterologous expression and characterization of bacterial 2-C-methyl-D-erythritol-4-phosphate pathway in Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 97, 5753–5769 (2013).
  CAS PubMed Google Scholar
• Lill, R. & Muhlenhoff, U. Maturation of iron–sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 77, 669–700 (2008).
  CAS PubMed Google Scholar
• Paradise, E. M., Kirby, J., Chan, R. & Keasling, J. D. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotechnol. Bioeng. 100, 371–378 (2008).
  CAS PubMed Google Scholar
• Asadollahi, M. A. et al. Production of plant sesquiterpenes in Saccharomyces cerevisiae: effect of ERG9 repression on sesquiterpene biosynthesis. Biotechnol. Bioeng. 99, 666–677 (2008).
  CAS PubMed Google Scholar
• Noble, M. A. et al. Roles of key active-site residues in flavocytochrome P450 BM3. Biochem. J. 339, 371–379 (1999).
  CAS PubMed PubMed Central Google Scholar
• Glieder, A., Farinas, E. T. & Arnold, F. H. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nature Biotech. 20, 1135–1139 (2002).
  CAS Google Scholar
• Dietrich, J. A. et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chem. Biol. 4, 261–267 (2009). This paper describes the adaptation of a high-activity bacterial cytochrome P450 enzyme for the production of an oxidized artemisinin precursor.
  CAS PubMed Google Scholar
• Ting, H. M. et al. The metabolite chemotype of Nicotiana benthamiana transiently expressing artemisinin biosynthetic pathway genes is a function of CYP71AV1 type and relative gene dosage. New Phytol. 199, 352–366 (2013).
  CAS PubMed Google Scholar